Genetic testing
HLA-B27 in practice
What a positive or negative HLA-B27 result really contributes to diagnosing inflammatory back pain and related conditions.
Key facts
At a glance
-
The association: HLA-B27 is carried by most people with ankylosing spondylitis - but also by around 1 in 12 healthy Britons.
-
The right question first: the test helps only when inflammatory back pain is genuinely suspected - young onset, morning stiffness, improvement with exercise.
-
How results move the dial: positive raises suspicion and can fast-track MRI; negative makes axial spondyloarthritis less likely without excluding it.
-
Beyond the back: B27 is relevant in acute anterior uveitis, reactive arthritis and some psoriatic and bowel-related arthritis.
-
Follow-up: a rheumatologist assembles gene, symptoms, inflammation markers and MRI - no single element diagnoses alone.
The full picture
What this test involves, and how to get it
HLA-B27 illustrates how a strong association behaves weakly in the wrong population. The gene is present in the large majority of people with ankylosing spondylitis - yet roughly 8% of the healthy UK population carries it, and only a small minority of carriers ever develop disease, so testing random back pain produces mostly meaningless positives. The test performs properly only after clinical filtering: back pain beginning before 45, present over three months, with inflammatory features - morning stiffness beyond half an hour, improvement with movement rather than rest, waking in the second half of the night, good response to anti-inflammatories. In that pre-selected group, B27 meaningfully shifts probability: a positive result strengthens the case and justifies MRI of the sacroiliac joints (which shows inflammation years before X-ray changes), while a negative result substantially lowers - without abolishing - the likelihood of axial spondyloarthritis.
B27 also earns its place beyond the spine: it links to acute anterior uveitis (sudden painful red eye - B27-positive patients with recurrent uveitis deserve screening questions about their backs), reactive arthritis after gut or genitourinary infections, and arthritis accompanying psoriasis and inflammatory bowel disease. The clinical stakes are timing: axial spondyloarthritis takes years on average to diagnose, years in which modern biologic treatments could have prevented damage. NHS testing is a simple blood test via GP or rheumatology, with the referral pathway the slower element; private rheumatology consultations with same-visit B27 testing and rapid MRI can compress the diagnostic journey into weeks - the assembled picture, not the gene alone, is what a rheumatologist reads.
A quiet reminder
This guide is for information, not medical advice.
Your own clinician knows your history and can tell you which parts apply to you. Next review of this page: 2027-09-27.
Frequently asked
Common questions about HLA-B27 in practice.
Quick, plain-English answers to what people ask us most.
-
What is HLA-B27 and what does the test show?
HLA-B27 is a genetic marker found on the surface of white blood cells. Testing shows whether you carry this particular gene variant, which is associated with a higher likelihood of certain inflammatory joint conditions, though carrying it does not mean you have or will develop such a condition.
-
Why would a doctor order an HLA-B27 test in practice?
It is typically used to support the diagnosis of conditions such as ankylosing spondylitis or reactive arthritis when someone has suggestive symptoms, like persistent back pain and stiffness in a younger adult, alongside other clinical findings.
-
Do I need to prepare for an HLA-B27 test?
No special preparation, fasting, or medication changes are required. It is a straightforward blood test.
-
What happens during the test?
A standard blood sample is taken from a vein and sent to a laboratory for genetic analysis.
-
How long do HLA-B27 results take?
Turnaround can vary, often around one to two weeks, since this involves a more specialised laboratory process than routine blood tests.
-
What does a positive HLA-B27 result mean in practice?
A positive result increases the likelihood that certain symptoms are related to an inflammatory arthritis, but many people carry the gene without ever developing symptoms, and the diagnosis still depends on your clinical picture, imaging, and other tests. It is a supporting piece of evidence, not a standalone diagnosis, and should be discussed with a rheumatologist or your doctor.
-
Is the HLA-B27 test reliable?
The test itself is a highly reliable way of detecting the gene variant, but its clinical usefulness depends entirely on context; a positive result in someone without relevant symptoms carries very different meaning than in someone with a classic clinical presentation.
-
How much does private HLA-B27 testing cost?
Private rheumatology clinics can arrange this test, usually as part of a wider assessment for inflammatory joint symptoms, with results reviewed by a specialist. Cost varies by provider.
-
Is HLA-B27 testing available on the NHS?
Yes, it is available on the NHS, typically arranged through a GP or rheumatologist when clinically indicated, though access to specialist rheumatology review can involve a wait.
-
How do I book this privately, and how quickly can I be seen?
Private rheumatology clinics can often arrange an initial consultation and testing within a week or two, offering a quicker path to specialist assessment than some routine NHS pathways.